ask="7.20"
ask_size="500"
average_daily_volume="873316"
bid="5.61"
bid_size="100"
book_value="0.05"
change="+0.05"
change_from_200_day_moving_average="2.40"
change_from_50_day_moving_average="0.89"
change_from_52_week_high="-2.34"
change_From_52_week_low="5.30"
change_in_percent="+0.73%"
close="6.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46336000"
high="7.02"
high_52_weeks="9.27"
last_trade_date="1/5/2017"
last_trade_price="6.93"
last_trade_size="84551"
last_trade_time="4:00pm"
low="6.74"
low_52_weeks="1.63"
market_capitalization="511.14M"
moving_average_200_day="4.53"
moving_average_50_day="6.04"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="6.87"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+53.13%"
percent_change_from_50_day_moving_average="+14.68%"
percent_change_from_52_week_high="-25.24%"
percent_change_from_52_week_low="+325.15%"
previous_close="6.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="127.41"
price_per_sales="23.10"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="13.23"
stock_exchange="NMS"
symbol="BCRX"
volume="994865"
weeks_range_52="1.63 - 9.27"
